Holen Sie sich die Stockscreener-App
0.6705
0.00%
0.00
Schlusskurs vom Vortag:
$0.6705
Offen:
$0.67
24-Stunden-Volumen:
17,578
Relative Volume:
0.14
Marktkapitalisierung:
$693.78K
Einnahmen:
$249.00K
Nettoeinkommen (Verlust:
$-6.90M
KGV:
-0.0478
EPS:
-14.0152
Netto-Cashflow:
$-6.65M
1W Leistung:
-14.85%
1M Leistung:
-26.48%
6M Leistung:
-65.08%
1J Leistung:
-93.45%
1-Tages-Spanne:
$0.67
$0.7086
1-Wochen-Bereich:
$0.6651
$0.78
52-Wochen-Spanne:
$0.6651
$10.74
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Firmenname
Bluejay Diagnostics Inc
Sektor
Branche
Telefon
(978) 631-0152
Adresse
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
0.6705 | 693.78K | 249.00K | -6.90M | -6.65M | -14.02 |
ABT
Abbott Laboratories
|
98.69 | 170.77B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.41 | 119.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.99 | 113.15B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.16 | 64.01B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 50.56B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bluejay Diagnostics Inc Aktie (BJDX) Neueste Nachrichten
Arrow Electronics, Inc. Common Stock (NY: ARW - The Chronicle-Journal
Bluejay Diagnostics Inc (NYSE: BJDX) Stock Price, News & Analysis - Kalkine
Bluejay Diagnostics (BJDX) Slips 1.94% to $1.01 as Micro-Cap Diagnostics Stock Tests Key SupportDonchian Channel - siam.in
Bluejay Diagnostics Inc (NYSE: BJDX) Stock Price, News & Analysis - kalkine.ca
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
Bluejay Diagnostics expands federal access via Lovell partnership - TipRanks
Bluejay Diagnostics Taps Lovell Government Services as Exclusive SDVOSB Distributor for U.S. Government - TradingView
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance - Yahoo Finance
BJDX Stock Gains Momentum On Sepsis Trial, Cash Boost - timothysykes.com
BJDX Stock Gains Momentum On Sepsis Trial, Cash Boost - timothysykes.com
BJDX Stock Draws Traders As Trial, Cash Runway And 13G Align - StocksToTrade
These stocks are moving in today's pre-market session - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
BJDX Stock Draws Traders As Cash, Trial And 13G Align - StocksToTrade
Bluejay Diagnostics, Inc. and Lovell Government Services, Inc. Announce Partnership to Expand Access to U.S. Federal Healthcare Markets - marketscreener.com
Premarket Movers for Sept. 8, 2026: Notable Gainers and Losers - ChartMill
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets - marketscreener.com
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets - ca.finance.yahoo.com
NASDAQ Stocks Under $1: FNGR, DUO, EPOW, CYAB in Focus Now! - FinancialContent
BJDX Stock Draws Traders As Sepsis Test Milestones Hit - StocksToTrade
Armistice Capital Acquires 142,728 Shares of Bluejay Diagnostics Inc (BJDX) - GuruFocus
Bluejay (BJDX) Session-Level Review: Loses 4.90% to Close at $0.97 at the Close; Reference Levels: the Session Ends Within the Reported Technical Boundaries for the Current SessionGrowth ETF - vinanet.vn
Bluejay (BJDX) Session-Level Review: Loses 4.90% to Close at $0.97 at the Close; Reference Levels: the Session Ends Within the Reported Technical Boundaries for the Current SessionMonthly Profile - siam.in
Bluejay Diagnostics (BJDX) links director options to FDA nod - Stock Titan
Bluejay Diagnostics (BJDX) links director’s 100K options to FDA clearance - Stock Titan
Bluejay Diagnostics (BJDX) ties director’s options to FDA device clearance - Stock Titan
Bluejay Diagnostics (NASDAQ: BJDX) insider updates share holdings - Stock Titan
Bluejay Diagnostics (NASDAQ: BJDX) ties director options to FDA clearance - Stock Titan
Armistice Capital discloses 9.99% Bluejay Diagnostics (BJDX) position in Schedule 13G - Stock Titan
Bluejay Diagnostics (BJDX) investor group discloses 9.99% ownership with warrants - Stock Titan
Form 8K Bluejay Diagnostics Inc For: 13 August By Investing.com - Investing.com Nigeria
Bluejay Advances Symphony Platform, Strengthens Cash Position - TipRanks
Form 8K Bluejay Diagnostics Inc For: 13 August By Investing.com - Investing.com Canada
Form 8K Bluejay Diagnostics Inc For: 13 August - Investing.com India
Form 8K Bluejay Diagnostics Inc For: 13 August By Investing.com - Investing.com UK
Bluejay Diagnostics Q2 Results: EPS loss narrows 80% YoY to $(1.12) - scanx.trade
Bluejay Diagnostics completes enrollment in sepsis test study - Investing.com
Bluejay Diagnostics completes enrollment in sepsis test study By Investing.com - Investing.com Australia
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization - The Manila Times
Bluejay Diagnostics Completes Enrollment in SYMON-II Pivotal Study, Advances Toward 510(k) Submission and Commercialization - quiverquant.com
Bluejay Diagnostics completes enrollment in sepsis test study By Investing.com - Investing.com UK
Bluejay completes 750-patient study enrollment for Symphony IL-6 - Stock Titan
Bluejay Diagnostics, Inc. Q2 2026: Net loss $(2.32M), EPS $(1.12) — 10-Q Summary - TradingView
Bluejay Diagnostics (BJDX) warns on going concern and Nasdaq listing risk - Stock Titan
BJDX Forecast & Price Target - TradingKey
Bluejay Diagnostics Inc (BJDX) Stock News Today - tradingkey.com
Why Are Traders Watching Bluejay Diagnostics (NASDAQ:BJDX) This Week? - Kalkine Media
Bullish Volume: RITR, IGC, BJDX, CISS Lead Active Sub-$1 Stocks to Watch - Barchart.com
Bullish Volume: RITR, IGC, BJDX, CISS Lead Active Sub-$1 Stocks to Watch - openpr.com
Finanzdaten der Bluejay Diagnostics Inc-Aktie (BJDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bluejay Diagnostics Inc-Aktie (BJDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Jul 10 '26 |
Sale |
1.40 |
34,938 |
48,913 |
92,055 |
| Wurth Douglas Clark | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,608 |
| Dey Indranil | President and CEO |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,522 |
| CHASE DONALD R | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,525 |
| ZEIDMAN FRED S | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,500 |
| Dey Svetlana | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,501 |
3.24%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):